Table E1.
Comparison between those subjects with follow-up data relating to asthma control at 4 weeks and those without
| Characteristic | Subjects with follow-up data (n = 319) | Subjects without follow-up data (n = 159) | P value |
|---|---|---|---|
| Age (y) | |||
| 2-4 | 60 (19) | 25 (16) | .65 |
| 5-11 | 157 (49) | 78 (49) | |
| 12+ | 102 (32) | 56 (35) | |
| Sex: male | 190 (60) | 98 (62) | .69 |
| Baseline asthma control score, median (IQR) | |||
| TRACK (age 2-4 y) | 50 (30-65) | 60 (38-75) | .20 |
| (c)ACT (age 5-11 y) | 19 (16-22) | 19 (13-23) | .34 |
| ACT (age 12+ y) | 19 (17-22) | 19 (14-22) | .16 |
| ACQ (age 5+ y) | 6 (2-10) | 6 (2-13) | .24 |
| Receiving high-dose ICSs | |||
| Age 2-4 y: ICS ≥ 400 μg/d | 33 (10) | 15 (9) | .87 |
| Age 5-11 y: ICS ≥ 800 μg/d | 40 (13) | 23 (14) | .57 |
| Age 12+ y: ICS ≥ 800 μg/d | 54 (17) | 43 (27) | .01 |
| Previous influenza vaccination | 225 (71) | 107 (67) | .53 |
| Previous LAIV | 156 (49) | 66 (42) | .14 |
IQR, Interquartile range.
Values are n (%) unless otherwise indicated.